REGENXBIO Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2018 to Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
REGENXBIO Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q1 2022.
- REGENXBIO Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was -$41K, a 1125% decline year-over-year.
- REGENXBIO Inc. annual Income Tax Expense (Benefit) for 2023 was -$152K, a 81% decline from 2022.
- REGENXBIO Inc. annual Income Tax Expense (Benefit) for 2022 was -$84K, a 101% decline from 2021.
- REGENXBIO Inc. annual Income Tax Expense (Benefit) for 2021 was $13.4M, a 156% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)